Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study evaluates rapid bacterial testing of platelets

Booth AL et al. AABB18, Abstract INV4

Publish date:: November 3, 2018

Key clinical point: Rapid bacterial testing of platelets can save money and reduce product wastage.

Major finding: Annualized cost savings with rapid bacterial testing were nearly $89,000; platelet wastage decreased from 24% to 10%.

Study details: A retrospective analysis of costs and product wastage before and after implementation of rapid bacterial testing.

Disclosures: The study was internally funded. The authors reported having no conflicts of interest.

Read the article here.

Citation:

Booth AL et al. AABB18, Abstract INV4

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,

All Specialties